Trichomoniasis test from BD lands FDA clearance

08/28/2013 | GenomeWeb Daily News (free registration)

BD Diagnostics has received FDA clearance for its ProbeTec Trichomonas vaginalis Qx Amplified DNA Assay. The test, which runs on the company's Viper System with XTR Technology, already has CE mark approval in Europe and is used to aid in the detection of trichomoniasis.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC